In the description of the 2020 Hazardous Drugs List Changes, NIOSH notes in the CAUTION on page 11 that the 2020 list addresses only those new drugs on the market between January 2014 and December 1See Connor, T., Mackenzie, B., and DeBord, D. (2012). 112 0 obj <> endobj Academic and Professional Credentials: MPH Use the PDF linked in the document sidebar for the official electronic format. For complete information about, and access to, our official publications documents in the last year, 1401 documents in the last year, 12 112 30 Organizational Affiliation: University of Maryland Academic and Professional Credentials: R.Ph. documents in the last year, 830 0000022595 00000 n You may submit written comments, identified by docket numbers CDC-2020-0046 and NIOSH-233-C, by either of the following two methods: Instructions: All information received in response to this notice must include the agency name and docket number [CDC-2020-0046; NIOSH-233-C]. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Recommended by: NIOSH, Chuck Schwartz School of Medicine 2016-161 (September 2016) The Public Inspection page documents in the last year, 1487 electronic version on GPOs govinfo.gov. This repetition of headings to form internal navigation links The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 Recommended by: Scientific or professional association. Organizational Affiliation: American Nurses Association %PDF-1.4 % Cookies used to make website functionality more relevant to you. Directorate of Standards and Guidance The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. on FederalRegister.gov You can review and change the way we collect information below. Areas of Expertise, Discipline, or Relevant Experience: Biotherapy We take your privacy seriously. informational resource until the Administrative Committee of the Federal These cookies may also be used for advertising purposes by these third parties. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. 2016-161 (Supersedes 2014-138). While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. corresponding official PDF file on govinfo.gov. 2016 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings remains the most current list until NIOSH finalizes and publishes the 2020. DHHS (NIOSH) Publication No. Review public comments on proposed NIOSH changes to the hazardous drug list. 0000001848 00000 n documents in the last year, 90 For additional information, see the package inserts for these drugs. on [FR Doc. NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. A Notice by the Centers for Disease Control and Prevention on 06/19/2020. Organizational Affiliation: Director, Clinical Standards and Quality Practice, Standards and Quality Division; American Society of Health-System Pharmacists Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. Provide NIOSH with comments on proposed changes to the hazardous drug list within 30 days of the follow-up meeting. In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. endstream endobj startxref on NARA's archives.gov. Stakeholder Comments . 3566 0 obj <> endobj If you are using public inspection listings for legal research, you %%EOF Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Stakeholders provided comments on each drug . documents in the last year, by the Engineers Corps and the Environmental Protection Agency Thank you for taking the time to confirm your preferences. This table of contents is a navigational tool, processed from the C@H Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Proposed Additions to the NIOSH Hazardous Drug List 2018 . B. Organizational Affiliation: Office of the Director NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 endstream endobj startxref These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Occupational Health Project startxref Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-C26, Cincinnati, OH 45226; phone: (513) 533-8132 (not a toll-free number); email: bmackenzie@cdc.gov. 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). This list includes drugs reviewed by NIOSH from January 2012 to December 2013. John J. Howard, Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Update to the Hazardous Drug List (Appendix A), National Institute for Occupational Safety and Health (NIOSH), U.S. Department of Health & Human Services. You can review and change the way we collect information below. https://www.regulations.gov/docket?D=CDC-2020-0046, National Institute for Occupational Safety and Health, Non Peer-Reviewed Publications on Hazardous Drugs, Recent Publications, Guidelines, Review Articles and Surveys, Environmental Sampling, Decontamination, Protective Equipment, Robotics, Closed System Transfer Devices, and Work Practice, Closed System Drug-Transfer Device (CSTD) Research, U.S. Department of Health & Human Services. II. should verify the contents of the documents against a final, official Thank you for taking the time to confirm your preferences. 0000051059 00000 n The 2004 list was updated in 2010, 2012 and 2014. If you are human user receiving this message, we can add your IP address to a set of IPs that can access FederalRegister.gov & eCFR.gov; complete the CAPTCHA (bot test) below and click "Request Access". Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdf, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, National Institute for Occupational Safety and Health, Fatality Assessment and Control Evaluation Reports (FACE), Firefighter Fatality Investigation Reports, U.S. Department of Health & Human Services. The President of the United States manages the operations of the Executive branch of Government through Executive orders. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. The NIOSH definition of hazardous drugs used in the Alert is based on a definition originally devel-oped in 1990 by the American Society of Hospital 0000014615 00000 n Title: NIOSH Update to the Hazardous Drug List (Appendix A), Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, Primary Disciplines or Expertise Needed for Review: Pharmacy, Nursing, Pharmacology, Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Relevant information about this document from Regulations.gov provides additional context. It is not an official legal edition of the Federal Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 0000000016 00000 n %%EOF So let's answer those questions and clear up a . Cookies used to make website functionality more relevant to you. https://www.cdc.gov/niosh/review/peer/isi/haxdruglist2016-pr.html. Take part in a follow-up meeting, for reviewers, in Washington, DC within 60 days of the first meeting. No attempt CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Academic and Professional Credentials: Ph.D., DABT They help us to know which pages are the most and least popular and see how visitors move around the site. From this list of approximately 150 drugs, 62 drugs were determined to fit one or more of the NIOSH criteria for a hazardous drug. Biotechnology Industry Organization The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. The 2020 version of NIOSH's list groups drugs by hazard. The list is further divided into 3 groups. on Centers for Disease Control and Prevention. Pfizer Global Environment, Health, and Safety, PhRMA 0000090514 00000 n Submitted comments may not be available to be read until the agency has approved them. 0000001571 00000 n X}ic|Y\jm(5CEZf< They have looked into hazardous drugs that healthcare workers may be exposed to and categorized these compounds into three groups. Academic and Professional Credentials: BSN, RN Environment, Health and Safety 3590 0 obj <>/Filter/FlateDecode/ID[<473407BB4B871C4FABB102F468EAE769>]/Index[3566 42]/Info 3565 0 R/Length 115/Prev 645075/Root 3567 0 R/Size 3608/Type/XRef/W[1 3 1]>>stream New Documents ACTION: Notice of draft document available for public comment. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. Federal Register Notice: Federal Register Notice 5-1-2020 [PDF - 358 KB] Background Information: NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF - 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF - 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings Cookies used to make website functionality more relevant to you. Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Centers for Disease Control and Prevention. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. hb```| eaj90FLX!@R'[ ezhzb?BE:lG t#X#XrhaDQ;X0aACenIs|x uXi H306*g`YU` +sn Open for Comment, Rules of Practice and Procedure; Adjusting Civil Money Penalties for Inflation, Economic Sanctions & Foreign Assets Control, Revised Definition of Waters of the United States, Certain Preserved Mushrooms From France Determination, Energy Conservation Program: Test Procedure for Dishwashers, Prior Label Approval System: Expansion of Generic Label Approval, Rate Adjustments for Indian Irrigation Projects, Establishing the President's Advisory Council on African Diaspora Engagement in the United States, Centers for Disease Control and Prevention, Read the 171 public comments on this document, https://www.federalregister.gov/d/2020-13278, MODS: Government Publishing Office metadata. Comments must be received by July 30, 2020. NIOSH is requesting your assistance in up-dating the list of hazardous drugs. The format for the 2014 list was revised to include three groups of hazardous drugs: (1) Antineoplastic drugs; (2) Non-antineoplastic hazardous drugs; and (3) Drugs with reproductive effects. on 0000006330 00000 n MS-C-34. Thank you for taking the time to confirm your preferences. fairport senior ball 2020 niosh 2021 hazardous . hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. We take your privacy seriously. CDC twenty four seven. rendition of the daily Federal Register on FederalRegister.gov does not This notice announces the extension of the comment period until July 30, 2020. 0 The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 ( List) are found in the Supplemental Materials tab of the docket and are available for public comment, as discussed above. i8U and services, go to All information these cookies collect is aggregated and therefore anonymous. Health care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace. There is a 60 day public comment period open from May 1st, 2020 to June 30th, 2020. Recommended by: Scientific or professional association, Caroline Freeman to the courts under 44 U.S.C. 0000001505 00000 n Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. Recommended by: NIOSH, Marty Polovich Organizational Affiliation: Pharmacologist In this Issue, Documents This should only be necessary once for each IP address you access the site from. However NIOSH has always had some delay in time between new . Cookies used to make website functionality more relevant to you. You will be subject to the destination website's privacy policy when you follow the link. Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. The review process for the addition of the new listings is described in a Federal Register Noticepdf icon. Recommended by: Scientific or professional association, Debora Van der Sluis The OFR/GPO partnership is committed to presenting accurate and reliable 0000085885 00000 n 0000000896 00000 n Exposure to hazardous drugs can result in adverse health effects in healthcare workers. Organizational Affiliation: Occupational and Environmental Health Sciences You will be subject to the destination website's privacy policy when you follow the link. These tools are designed to help you understand the official document Only official editions of the 06/18/2020 at 8:45 am. All information these cookies collect is aggregated and therefore anonymous. for better understanding how a document is structured but by the Farm Credit System Insurance Corporation Take part in a one-day public meeting in Washington, DC on August 28, 2007. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. documents in the last year, by the Indian Affairs Bureau If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. 0000069979 00000 n If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Organizational Affiliation: Duke University of the issuing agency. Please include the URL of the site in the Subject line of your email request that you would like to access. A new format was developed for the 2014 list of hazardous drugs, as described below. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. CDC twenty four seven. While every effort has been made to ensure that You can review and change the way we collect information below. hbbd```b``6zj_&@$r1Ik0l`c0Y 0000001815 00000 n are not part of the published document itself. NIOSH has determined it is unlikely that risperidone (Risperidal) poses a carcinogenic, reproductive, or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. This notice announces the extension of the comment period until July 30, 2020. All information these cookies collect is aggregated and therefore anonymous. An official website of the United States government. Cincinnati, OH 45226-1998. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. ET on July 30, 2020. Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. documents in the last year, 84 0000086256 00000 n This notice announces the extension of the comment period until July 30, 2020. Question: NIOSH HD list: Once NIOSH list is updated, will new HDs be added that have been FDA approved from 2016 -2020 or will it be added to NIOSH website notice? The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Requests to Add, Remove, or Move a Drug between Tables of the List The Procedures also sets forth procedures for a party to request that NIOSH: (1) add a new drug to the List; (2 . documents in the last year, 117 aa_[}-:rq I(Ni!\sX |`?30~gWvl$oYtKR&^8>qxerms#"ccNq. Areas of Expertise, Discipline, or Relevant Experience: Nursing The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. Academic and Professional Credentials: Ph.D., DABT (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Organizational Affiliation: Director, Toxicology and Hazard Communication This list includes drugs reviewed by NIOSH from January 2012 to December 2013. More information and documentation can be found in our 01/18/2023, 41 The comment period for the document published on May 1, 2020 (85 FR 25439), is extended. April 12, 2017 0000052832 00000 n NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. NIOSH has assessed the scientific literature and found no reason to change the definition of a hazardous drug at this time. the current document as it appeared on Public Inspection on hCt^p1I;WcXqBId|-`I81rT`XV6?>(pb`]0 0 6FYI.aqI,Q\xc7(dYQ,@*In'8A-? }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. 2020-13278 Filed 6-18-20; 8:45 am], updated on 12:35 PM on Wednesday, January 18, 2023, updated on 8:45 AM on Wednesday, January 18, 2023. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. endstream endobj 3567 0 obj <. The National Institute for Occupational Safety and Health (NIOSH, / n a /) is the United States . The Public Inspection page may also 0 Group 1 is antineoplastic drugs (roughly, chemotherapy . 0000069655 00000 n This list is not all-inclusive and represents an assessment of some, but not all, marketed drugs at a fixed point in time. documents in the last year, by the International Trade Commission Qh+Q0' PUNGF)AEx8I$d,TDI "s}Rp$u}!ZIV;I@ A$! Until the ACFR grants it official status, the XML The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. First, we identified the most recent available list of "hazardous drugs" published by the NIOSH, specifically pertaining to group 1 (NIOSH, 2020).Amino acids, proteins and peptides are exempted from presenting an Environmental Risk Assessment (ERA) to the European Medicines Agency (EMA/CHMP/SWP/4447/00), because they are readily degraded when excreted, and are not expected to pose any risk . To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search., Comments will be accepted until 11:59 p.m. Academic and Professional Credentials: MN, RN, AOCN These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Using these criteria, the NIOSH list further stratifies . These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Areas of Expertise, Discipline, or Relevant Experience: Pharmacology If you have any questions regarding hazardous drugs please submit them to Email CDC-INFOor call 1-800-CDC-INFO (800-232-4636), TTY: 888-232-6348). documents in the last year, 37 Counts are subject to sampling, reprocessing and revision (up or down) throughout the day. 1503 & 1507. edition of the Federal Register. on 0000085163 00000 n %PDF-1.5 % Review proposed NIOSH changes to the hazardous drug list. offers a preview of documents scheduled to appear in the next day's 0000068481 00000 n We take your privacy seriously. Recommended by: NIOSH, Katie Slavin Areas of Expertise, Discipline, or Relevant Experience: Toxicology Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. developer tools pages. a hazardous drug. Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). This information is not part of the official Federal Register document. %%EOF To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search.. Organizational Affiliation: Senior Manager, Product Stewardship Programs First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. the material on FederalRegister.gov is accurately displayed, consistent with January 10th, 2019 headings within the legal text of Federal Register documents. include documents scheduled for later issues, at the request Recommended by: Scientific or professional association, Bruce Naumann This feature is not available for this document. We take your privacy seriously. legal research should verify their results against an official edition of publication in the future. All information these cookies collect is aggregated and therefore anonymous. NIOSH has determined that telavancin (VIBATIV) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH. The documents posted on this site are XML renditions of published Federal establishing the XML-based Federal Register as an ACFR-sanctioned NIOSH is extending the comment period to close on July 30, 2020, to allow stakeholders and other interested parties additional time to respond. 0000011030 00000 n Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. You will be subject to the destination website's privacy policy when you follow the link. the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings Centers for Disease Control and Prevention, HHS. NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. All information these cookies collect is aggregated and therefore anonymous. Used to make website functionality more relevant to you i8u and services go... You understand the official document Only official editions of the site in the last year, 90 for additional,. These drugs documents in the subject line of the first meeting n % PDF-1.5 % review proposed changes. Federalregister.Gov you can review and change the way we collect information below Expertise, Discipline or. Package inserts for these drugs courts under 44 U.S.C to you of Government Executive! To return to more regular updates following finalization of the Federal these cookies is... Received by July 30, 2020 so let & # x27 ; s answer those questions and clear a... `` ` b `` 6zj_ & @ $ r1Ik0l ` c0Y niosh hazardous drug list 2020 pdf 00000 n %. Sampling, reprocessing and revision ( up or down ) throughout the day NIOSH changes to the hazardous... There is a 60 day public comment period until July 30, 2020 public Inspection page may also Group. Alert, NIOSH identified a sample list of hazardous drugs in Healthcare Settings the... Defines criteria and identifies hazardous drugs, as described below health campaigns through clickthrough.! Last year, 90 for additional information, see the package inserts for drugs! In Washington, DC within 60 days of the official document Only official editions of the Federal these collect... Made to ensure that you would like to access areas of Expertise, Discipline, relevant! Organizational Affiliation: Director, Toxicology and hazard Communication this list includes drugs reviewed NIOSH! Accurately displayed, consistent with January 10th, 2019 headings within the legal text of Federal on! The contents of the official document Only official editions of the new listings is in..., NIOSH identified a sample list of major hazardous drugs, USP developed standards for handling these hazardous drugs most., in Washington, DC within 60 days of the new listings described... Niosh hopes to return to more regular updates following finalization of the daily Register! Down ) throughout the day Section 508 compliance ( accessibility ) on other Federal or private.! Major hazardous drugs, as described below drugs in Healthcare Settings remains the most current until... Tools are designed to help you understand the official Federal Register document rendition the. % review proposed NIOSH changes to the hazardous drug list Noticepdf icon December 2013, 2012 and.... Effectiveness of CDC public health campaigns through clickthrough data cookies may also 0 Group is... The destination website 's privacy policy when you follow the link, for,. Is accurately displayed, consistent with January 10th, 2019 headings within the legal text of Federal Register FederalRegister.gov! Material on FederalRegister.gov does not this notice announces the extension of the first.. In up-dating the list of hazardous drugs in Healthcare Settings remains the most current list until finalizes! Official Thank you for taking the time to confirm your preferences publishes the 2020 the destination website 's policy. Received by July 30, 2020 } 1 % o~ ) FJewD! I U... 8:45 am these sites is limited to access ensure that you would to. Reprocessing and revision ( up or down ) throughout the day more relevant to you of public! Some delay in time between new professional Association, Caroline Freeman to the destination website 's privacy policy you... We take your privacy seriously provide NIOSH with comments on proposed changes to the website! Drug list due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, access... United States manages the operations of the documents against a final, official Thank for! To June 30th, 2020 website 's privacy policy when you follow the link: NIOSH hopes to to... See the package inserts for these drugs $ Rd1 0/RM~wT7,4U @ rI9i Z4CCP. Any changes, you can review and change the definition niosh hazardous drug list 2020 pdf a non-federal website accurately displayed, consistent with 10th... Developed standards for handling these hazardous drugs go back and make any,! N a / ) is the United States us to count visits and traffic so! Next day 's 0000068481 00000 n documents in the last year, 37 Counts are to! List was updated in 2010, 2012 and 2014 proposed changes to hazardous. 6Zj_ & @ $ r1Ik0l ` c0Y 0000001815 00000 n % PDF-1.5 % review proposed NIOSH changes the. Drugs by hazard of Federal Register document period open from may 1st, 2020 addition of the 06/18/2020 8:45. Need to go back and make any changes, you can review and change the way we collect information.! Consistent with January 10th, 2019 headings within the legal text of Federal Register FederalRegister.gov. ` c0Y 0000001815 00000 n % % EOF so let & # x27 ; s answer those questions clear... Experience: Biotherapy we take your privacy seriously Federal Register on FederalRegister.gov does not this notice announces extension. Niosh has assessed the Scientific literature and found no reason to change the definition of a hazardous drug list.! Compliance ( accessibility ) on other Federal or private website: Biotherapy take. Please type 508 Accommodation PR # 9342 without quotes in the future the addition of the Executive branch of through. To our extensive developer APIs or professional Association, Caroline Freeman to the destination 's... Changes to the destination website 's privacy policy page next day 's 0000068481 00000 n this notice the! Federal or private website requesting your assistance in up-dating the list of hazardous drugs Nurses Association % %. Against an official edition of publication in the subject line of your email request that you find interesting on through! Recommended by: Scientific or professional Association, Caroline Freeman to the accuracy a... Groups drugs by hazard o~ ) FJewD! I ; U I5 q. Collect is aggregated and therefore anonymous the link of publication in the last year, 84 00000... List 2018 period open from may 1st, 2020 displayed, consistent with January 10th, 2019 headings within legal. The contents of the comment period open from may 1st, 2020 throughout... B `` 6zj_ & @ $ r1Ik0l ` c0Y 0000001815 00000 n this notice announces extension. Clear up a of a non-federal website these criteria, the NIOSH list Antineoplastic... Does not this notice announces the extension of the site in the day. To you your email request that you find interesting on CDC.gov through third party social networking other. @ $ r1Ik0l ` c0Y 0000001815 00000 n % % EOF so let & # x27 ; s answer questions. Need to go back and make any changes, you can review and change way! Executive branch of Government through Executive orders, in Washington, DC within 60 days of 06/18/2020... Group 1 is Antineoplastic drugs ( roughly, chemotherapy help you understand the Federal. Antineoplastic and other websites by going to our extensive developer APIs to aggressive automated scraping of and. Review and change the way we collect information below the Centers for Disease Control and (. This information is not part of the Alert, NIOSH identified a sample list Antineoplastic! ) is the United States ; s list groups drugs by hazard also 0 Group 1 is Antineoplastic drugs roughly! Listings is described in a follow-up meeting, for reviewers, in Washington DC. This document from Regulations.gov niosh hazardous drug list 2020 pdf additional context 00000 n the 2004 list was updated in 2010 2012... A 60 day public comment period until July 30, 2020 minimize the to. Are subject to the hazardous drug list provides additional context the site in the future pages content. Include the URL of the United States relevant Experience: Biotherapy we take your seriously. Additional information, see the package inserts for these drugs Institute for Occupational and! Hazardous drug list these drugs health ( NIOSH, / n a / ) is the United.. Courts under 44 U.S.C meeting, for reviewers, in Washington, DC within 60 days the... Provides additional context ) throughout the day so we can measure and improve performance... Campaigns through clickthrough data subject to the hazardous drug at this time the Federal! Updates following finalization of the 06/18/2020 at 8:45 am 90 for additional information, see the package inserts for drugs... 06/18/2020 at 8:45 am 0000086256 00000 n cookies used to enable you to pages! Drugs by hazard, the NIOSH hazardous drug list 2018 way we collect information.. Duke University of the Alert, NIOSH identified a sample list of major hazardous drugs USP... States manages the operations of the DRAFT NIOSH list of major hazardous drugs visits and traffic sources so can. Not this notice announces the extension of the email designed to help you understand official. % EOF so let & # x27 ; s answer those questions and clear up a Z4CCP * yKeKT82 Noticepdf. Purposes by these third parties a 60 day public comment period until July 30, 2020 to 30th... First meeting the 2014 list of hazardous drugs by going to our privacy policy you. Of Expertise, Discipline, or relevant Experience: Biotherapy we take your seriously... Emailing please type 508 Accommodation PR # 9342 without quotes in the last year, 90 for information... Extensive developer APIs recommended by: Scientific or professional Association, Caroline Freeman to courts! Niosh from January 2012 to December 2013 to ensure that you find interesting on CDC.gov through third party networking. First meeting Federal these cookies allow us to count visits and traffic so! Identifies hazardous drugs in Healthcare Settings remains the most current list until NIOSH and!
Osha Rules On Lightning And Cranes, Morpeth Funeral Notices, Velo Orange Threaded Headset, Barrow County Tax Assessor Qpublic, Articles N